Abstract
The present invention is directed to aspartic protease inhibitors. Certain aspartic protease inhibitors of the invention can be represented by the following structural formula or a pharmaceutically acceptable salt thereof. The present invention is also directed to pharmaceutical compositions comprising the disclosed aspartic protease inhibitors. The present invention is further directed to methods of antagonizing one or more aspartic proteases in a subject in need thereof, and methods for treating an aspartic protease mediated disorder in a subject using the disclosed aspartic protease inhibitors. [on SciFinder (R)]
Cite
CITATION STYLE
Klebe, G. (2013). Aspartic Protease Inhibitors. In Drug Design (pp. 533–564). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-17907-5_24
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
